Preferred Label : metreleptin;
MeSH note : MW about 16 kDa; RN & amino acid sequence in first source; recombinant form of human
leptin;
CISMeF synonym : Myalept;
MeSH synonym : n-methionylleptin;
Registry Number MeSH : 186018-45-1;
Is substance : O;
UNII : TL60C27RLH;
Origin ID : C415771;
UMLS CUI : C0961965;
ATC code(s)
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://ansm.sante.fr/tableau-marr/metreleptine
2022
false
false
false
France
French
risk management
guidelines for drug use
metreleptin
metreleptin
metreleptin
injections, subcutaneous
drug compounding
withdrawing treatment
Leptin Deficiency
lipodystrophy
continuity of patient care
pregnancy
---
https://www.has-sante.fr/portail/jcms/c_2913097/fr/myalepta
https://www.has-sante.fr/portail/jcms/c_2913097/fr/myalepta-metreleptine-analogue-recombinant-de-la-leptine-humaine
2019
false
true
false
false
France
French
treatment outcome
orphan drug production
metreleptin
metreleptin
lipodystrophy, congenital generalized
lipodystrophy, familial partial
adult
adolescent
Acquired partial lipodystrophy
Acquired generalized lipodystrophy
injections, subcutaneous
leptin
evaluation of the transparency committee
insurance, health, reimbursement
survival analysis
leptin
leptin
guidelines for drug use
---
Myalepta metreleptin
https://www.ema.europa.eu/medicines/human/EPAR/Myalepta
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
metreleptin
metreleptin
metreleptin
drug approval
europe
lipodystrophy, congenital generalized
lipodystrophy, familial partial
adult
adolescent
Acquired partial lipodystrophy
Acquired generalized lipodystrophy
injections, subcutaneous
leptin
drug interactions
pregnancy
drug evaluation, preclinical
---